High potency improvements to weak aryl uracil HCV polymerase inhibitor leads

Pamela Donner1, John T Randolph, Peggy Huang

  • 1AbbVie, Department R4AJ, Building AP52N, 1 North Waukegan Road, North Chicago, IL 60064, United States. pamela.l.donner@abbvie.com